Adult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case report

J Med Case Rep. 2017 Jun 27;11(1):172. doi: 10.1186/s13256-017-1344-x.

Abstract

Background: Adult hemophagocytic lymphohistiocytosis is a secondary immunopathologic phenomenon, mainly secondary to malignancy, infection, or autoimmune disorders. The performance of diagnostic criteria, studied in the pediatric population, is yet to be validated in the adult population. Some of the criteria include cytopenias and organomegaly that are inherent features to malignant processes, thus making the diagnosis of hemophagocytic lymphohistiocytosis a challenge in patients with cancer.

Case presentation: We describe the case of a 54-year-old white man with history of metastatic maxillary sinus adenoid cystic carcinoma who had severe liver injury and cytopenias with progressive clinical deterioration. We performed an evaluation, by flow cytometry, of the expression of surface markers in his natural killer cells that revealed remarkable abnormalities. His syndrome eventually fulfilled criteria for hemophagocytic lymphohistiocytosis and he received therapy with steroids with interval clinical improvement. Unfortunately, he refused further cytotoxic treatment and died 2 weeks later.

Conclusions: The conventional criteria for the diagnosis of hemophagocytic lymphohistiocytosis are suboptimal for adult patients with cancer resulting in delays in diagnosis and timely initiation of treatment. The diagnostic criteria have to be re-evaluated in patients with cancer; novel, easily available, and accurate diagnostic methods are needed.

Keywords: Adult; Cancer; Diagnosis; Hemophagocytosis.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Adenoid Cystic / complications*
  • Fatal Outcome
  • Flow Cytometry
  • Humans
  • Killer Cells, Natural / immunology
  • Lymphohistiocytosis, Hemophagocytic / complications*
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphohistiocytosis, Hemophagocytic / immunology
  • Male
  • Middle Aged
  • Multiple Organ Failure

Substances

  • Biomarkers, Tumor